We are live on ! Find out more
TECX

Tectonic Therapeutic

79 hedge funds and large institutions have $38.8M invested in Tectonic Therapeutic in 2022 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 23 increasing their positions, 30 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

9,300% more call options, than puts

Call options by funds: $188K | Put options by funds: $2K

1.1% less ownership

Funds ownership: 6.7%5.6% (-1.1%)

14% less funds holding

Funds holding: 9279 (-13)

23% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 30

54% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 24

71% less capital invested

Capital invested by funds: $135M → $38.8M (-$96M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
79
Holders Change
-13
Holders Change %
-14.13%
% of All Funds
1.25%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
11
Increased
23
Reduced
30
Closed
24
Calls
$188K
Puts
$2K
Net Calls
+$186K
Net Calls Change
-$382K
Name Holding Trade Value Shares
Change
Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$5.97M
BlackRock
2
BlackRock
New York
$5M +$573K +27,720 +10%
GC
3
GMT Capital
Georgia
$3.42M
Federated Hermes
4
Federated Hermes
Pennsylvania
$3.23M -$252K -12,203 -6%
JP Morgan Chase
5
JP Morgan Chase
New York
$2.63M -$4.38M -211,837 -56%
Vanguard Group
6
Vanguard Group
Pennsylvania
$1.42M -$1.04M -50,495 -36%
ACM
7
Aisling Capital Management
New York
$1.33M
Acadian Asset Management
8
Acadian Asset Management
Massachusetts
$1.2M +$972K +47,042 +162%
Renaissance Technologies
9
Renaissance Technologies
New York
$1.17M +$971K +47,008 +176%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$984K +$164K +7,956 +15%
FCM
11
Farallon Capital Management
California
$977K
Two Sigma Advisers
12
Two Sigma Advisers
New York
$892K +$451K +21,834 +63%
Two Sigma Investments
13
Two Sigma Investments
New York
$888K +$345K +16,708 +42%
MB
14
MPM BioImpact
Massachusetts
$855K
State Street
15
State Street
Massachusetts
$826K -$366K -17,724 -25%
Citadel Advisors
16
Citadel Advisors
Florida
$816K +$165K +7,968 +18%
Millennium Management
17
Millennium Management
New York
$692K -$193K -9,328 -18%
AQR Capital Management
18
AQR Capital Management
Connecticut
$657K +$727K +35,184 +557%
D.E. Shaw & Co
19
D.E. Shaw & Co
New York
$635K +$726K +35,148 +709%
Morgan Stanley
20
Morgan Stanley
New York
$617K +$291K +14,088 +57%
GCP
21
GSA Capital Partners
United Kingdom
$447K +$207K +10,024 +55%
Northern Trust
22
Northern Trust
Illinois
$425K -$39.7K -1,923 -7%
NLVP
23
New Leaf Venture Partners
New York
$417K
EP
24
Eversept Partners
New York
$390K -$16.6K -802 -3%
Goldman Sachs
25
Goldman Sachs
New York
$359K -$1.91M -92,501 -80%

TECX Hedge Fund Activity: Q1 2022 in Review

79 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Tectonic Therapeutic (TECX) for Q1 2022, worth a combined $38.8M — down 71% from $135M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of TECX and 11 opened new positions — a net loss of 13 holders — while 30 trimmed existing stakes and 23 added.

The largest buyer was Acadian Asset Management, adding an estimated $972K. The largest seller was Camber Capital Management, exiting entirely with an estimated $6.29M sold.

  • 79 institutional investors held Tectonic Therapeutic (TECX) as of Q1 2022, down from 92 in Q4 2021.
  • Funds reported $38.8M of Tectonic Therapeutic stock for Q1 2022, down 71% quarter-over-quarter.
  • 11 funds opened new Tectonic Therapeutic positions in Q1 2022 and 24 closed out, a net change of -13 holders.
  • The largest Tectonic Therapeutic buyer in Q1 2022 was Acadian Asset Management, an estimated $972K added.
  • The largest Tectonic Therapeutic seller in Q1 2022 was Camber Capital Management, an estimated $6.29M sold.

Based on aggregated 13F filings for Q1 2022.